Novogene

Novogene (Stock Code: 688315) was registered and established in March 2011 at the Zhongguan Village Life Science Park in Beijing. It focuses on the application of cutting-edge molecular biology technologies and high-performance computing in life science research and human health, striving to become a global leader in providing gene technology products and services. The company's headquarters is located in Beijing, with laboratories or experimental bases in Tianjin, Guangzhou, Shanghai, the United States, the United Kingdom, and Singapore. It also has subsidiaries in Hong Kong, the United States, the United Kingdom, Singapore, the Netherlands, and Japan, covering an office area of over 40,000 square meters. Currently, Novogene has built a high-quality interdisciplinary team from prestigious universities both domestically and internationally, with master's degrees and above accounting for approximately 52%. The company has established high-throughput large-scale gene sequencing and high-performance computing platforms, effectively supporting the big data analysis and storage needs of life science research and healthcare. Its business covers about 90 countries and regions across six continents globally, serving nearly 7,000 customers. Novogene has established extensive cooperative relationships with numerous academic institutions worldwide, completing several genomic research projects of international advanced standards. As of June 2023, it has co-authored or been mentioned in approximately 20,000 SCI articles, with a cumulative impact factor of nearly 120,000. It has obtained 320 software copyrights and 62 patents so far. Its partners are spread across the globe, including more than 3,700 scientific research institutes and universities, over 650 hospitals, and more than 2,600 pharmaceutical and agricultural enterprises. As one of the leading companies in China’s gene sequencing field, Novogene's businesses cover basic life science research services, medical research and technical services, and library construction sequencing platform services, providing gene sequencing, mass spectrometry analysis, and bioinformatics technical support services to research universities, scientific research institutes, hospitals, pharmaceutical R&D enterprises, and agricultural enterprises worldwide.